Renal Cancer - Results from #4040

Papillary Adenomas and Other Small Epithelial Tumors in the Kidney: An Autopsy Study November 15, 2018

Patterns of practice and pharmacoeconomic analysis of the management of patients with metastatic renal cell carcinoma (mRCC) in Greece - the CRISIS study. A retrospective analysis by the Hellenic Genitourinary Cancer Group (HGUCG) November 15, 2018

Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis November 15, 2018

Nivolumab therapy for metastatic collecting duct carcinoma after nephrectomy: A case report November 14, 2018

Focal therapy versus robot-assisted partial nephrectomy in the management of clinical T1 renal masses: A systematic review and meta-analysis November 14, 2018

Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma November 14, 2018

Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma November 14, 2018

EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis November 14, 2018

Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma November 13, 2018

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial November 13, 2018

Huge mucinous tubular and spindle cell carcinoma of kidney: A rare case report and literature review November 13, 2018

CIP2A Promotes Proliferation, Invasion and Chemoresistance to Cisplatin in Renal Cell Carcinoma November 13, 2018

Identifying a Novel Biomarker TOP2A of Clear Cell Renal Cell Carcinoma (ccRCC) Associated with Smoking by Co-Expression Network Analysis November 13, 2018

[Renal cell carcinoma in von Hippel-Lindau disease. Nephron sparing surgery.] November 12, 2018

Combining DNA vaccine and AIM2 in H1 nanoparticles exert anti-renal carcinoma effects via enhancing tumor-specific multi-functional CD8+ T cell responses November 12, 2018

Phase III Trial of Adjuvant Sunitinib in Patients With High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis November 12, 2018

Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison November 12, 2018

MDACC 2018: Systemic Therapy for Metastatic Non-Clear Cell Histology Patients: What Works and What Doesn’t? November 11, 2018

MDACC 2018: Promising Emerging Systemic Therapies for mRCC November 11, 2018

MDACC 2018: Debate: Is There Still a Role for Cytoreductive Nephrectomy in the Setting of Metastatic Renal Cell Carcinoma? November 11, 2018

Page 203 of 456